DrugPatentWatch Database Preview
Chartwell Molecules Company Profile
What is the competitive landscape for CHARTWELL MOLECULES, and what generic and branded alternatives to CHARTWELL MOLECULES drugs are available?
CHARTWELL MOLECULES has twenty-one approved drugs.
Summary for Chartwell Molecules
| US Patents: | 0 |
| Tradenames: | 16 |
| Ingredients: | 16 |
| NDAs: | 21 |
Drugs and US Patents for Chartwell Molecules
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Molecules | ONDANSETRON | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 077406-004 | Dec 26, 2006 | DISCN | No | No | Start Trial | Start Trial | |||||
| Chartwell Molecules | CIPROFLOXACIN HYDROCHLORIDE | ciprofloxacin hydrochloride | TABLET;ORAL | 076896-003 | Nov 4, 2004 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Chartwell Molecules | ONDANSETRON HYDROCHLORIDE | ondansetron hydrochloride | TABLET;ORAL | 077303-004 | Jun 25, 2007 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
